日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Anaplasma marginale Tyrosine--tRNA ligase (tyrS) CSB-YP712546AAAC
CSB-EP712546AAAC
CSB-BP712546AAAC
CSB-MP712546AAAC
CSB-EP712546AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP712547AAAC
CSB-EP712547AAAC
CSB-BP712547AAAC
CSB-MP712547AAAC
CSB-EP712547AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale ATP synthase subunit alpha (atpA), partial CSB-YP712548AAAC
CSB-EP712548AAAC
CSB-BP712548AAAC
CSB-MP712548AAAC
CSB-EP712548AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale SsrA-binding protein (smpB) CSB-YP712549AAAC
CSB-EP712549AAAC
CSB-BP712549AAAC
CSB-MP712549AAAC
CSB-EP712549AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Nucleoside diphosphate kinase (ndk) CSB-YP712550AAAC
CSB-EP712550AAAC
CSB-BP712550AAAC
CSB-MP712550AAAC
CSB-EP712550AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Protein translocase subunit SecA (secA), partial CSB-YP712551AAAC
CSB-EP712551AAAC
CSB-BP712551AAAC
CSB-MP712551AAAC
CSB-EP712551AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale ATP synthase subunit a (atpB), partial CSB-YP712552AAAC1
CSB-EP712552AAAC1
CSB-BP712552AAAC1
CSB-MP712552AAAC1
CSB-EP712552AAAC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Pantothenate synthetase (panC) CSB-YP712553AAAC
CSB-EP712553AAAC
CSB-BP712553AAAC
CSB-MP712553AAAC
CSB-EP712553AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Glycerol-3-phosphate dehydrogenase [NAD (P)+] (gpsA) CSB-YP712554AAAC
CSB-EP712554AAAC
CSB-BP712554AAAC
CSB-MP712554AAAC
CSB-EP712554AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP712555AAAC
CSB-EP712555AAAC
CSB-BP712555AAAC
CSB-MP712555AAAC
CSB-EP712555AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 60 kDa chaperonin (groL), partial CSB-YP712556AAAC
CSB-EP712556AAAC
CSB-BP712556AAAC
CSB-MP712556AAAC
CSB-EP712556AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale Phosphoglucosamine mutase (glmM) CSB-YP712557AAAC
CSB-EP712557AAAC
CSB-BP712557AAAC
CSB-MP712557AAAC
CSB-EP712557AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S10 (rpsJ) CSB-YP712558AAAC
CSB-EP712558AAAC
CSB-BP712558AAAC
CSB-MP712558AAAC
CSB-EP712558AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S19 (rpsS) CSB-YP712559AAAC
CSB-EP712559AAAC
CSB-BP712559AAAC
CSB-MP712559AAAC
CSB-EP712559AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S3 (rpsC) CSB-YP712560AAAC
CSB-EP712560AAAC
CSB-BP712560AAAC
CSB-MP712560AAAC
CSB-EP712560AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S17 (rpsQ) CSB-YP712561AAAC
CSB-EP712561AAAC
CSB-BP712561AAAC
CSB-MP712561AAAC
CSB-EP712561AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 50S ribosomal protein L24 (rplX) CSB-YP712562AAAC
CSB-EP712562AAAC
CSB-BP712562AAAC
CSB-MP712562AAAC
CSB-EP712562AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 50S ribosomal protein L18 (rplR) CSB-YP712563AAAC
CSB-EP712563AAAC
CSB-BP712563AAAC
CSB-MP712563AAAC
CSB-EP712563AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 50S ribosomal protein L15 (rplO) CSB-YP712564AAAC
CSB-EP712564AAAC
CSB-BP712564AAAC
CSB-MP712564AAAC
CSB-EP712564AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaplasma marginale 30S ribosomal protein S11 (rpsK) CSB-YP712565AAAC
CSB-EP712565AAAC
CSB-BP712565AAAC
CSB-MP712565AAAC
CSB-EP712565AAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×